Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (lucent): study protocol for a multicenter randomized controlled trial

HIGHLIGHTS

• who: Ying Chen from the Beijing University of Chinese Medicine, Beijing, China have published the research work: Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial, in the Journal: (JOURNAL) of May/16,/2020
• what: In this multicenter randomized and controlled trial the authors aim to compare lumbrokinase plus aspirin versus aspirin alone in patients with acute ischemic stroke. The authors aim to investigate the efficacy and safety of lumbrokinase plus aspirin as compared to aspirin alone in the treatment of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.